Cannabinoid Oral Delivery Technology
Proprietary tablet platform enables
Controlled and consistent cannabinoid dosing
Enhanced bioavailability compared to conventional formats
Scalable
Improved stability and shelf-life
Scalable, GMP-compatible manufacturing
Clinical Evaluation
Clinical Evaluation
Unlike inhalation or oil-based delivery systems, tablet formulations provide a standardized format suitable for clinical evaluation and regulatory approval pathways.